NCRI 2019: Blood test for tumor-associated autoantibodies could detect breast cancer before clinical signs

Written by Louis Gautier, Future Science Group

A new blood test has been developed that could detect breast cancer up to 5 years before any clinical signs appear. Researchers from the University of Nottingham (UK) use the presence of autoantibodies that compliment tumor-associated antigens to diagnose breast cancer earlier. A pilot study conducted by the Centre of Excellence for Autoimmunity in Cancer, based at the University of Nottingham (UK), have developed a blood test for the early detection of breast cancer. The research group used screening technology to determine the presence of tumor-associated antigens (TAA), which are indicative of breast cancer and can be detected up to...

To view the full article, please register now for access

It's completely free